Molecule Details
| InChIKey | DXPOSRCHIDYWHW-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.8 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13781 |
|---|---|
| Drug Name | Xamoterol |
| CAS Number | 81801-12-9 |
| Groups | approved |
| ATC Codes | C01CX07 |
| Description | Xamoterol is a β1-adrenoceptor partial agonist that has shown to improve systolic and diastolic function in studies with heart failure patients. It modulates the sympathetic control of the heart but has no agonist action on β2-adrenoceptors. |
Categories: Adrenergic Agents Adrenergic Agonists Adrenergic beta-1 Receptor Agonists Adrenergic beta-Agonists Agents producing tachycardia Agents that produce hypertension Alcohols Amines Amino Alcohols Cardiac Stimulants Excl. Cardiac Glycosides Cardiac Therapy Morpholines Neurotransmitter Agents Oxazines Phenoxypropanolamines Propanolamines Propanols
Cross-references: ChEBI: 10055 CHEMBL75753 ChemSpider: 137213 C11775 D06328 PubChem:155774 PubChem:347829315 RxCUI: 39801 Wikipedia: Xamoterol